ࡱ> )` Ribjbj{{>#%<<<P8P@44"VVV!!!?@A@A@A@A@A@A@$Ch(FBe@Q<:&!^!:&:&e@VV/@+++:&jRV<V?@+:&?@++;"<<V( p/k);s>@0@;jGD*jG(<jG<<!#+#q$!!!e@e@J+^!!!@:&:&:&:&PPPPPPPPP Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Shandong Xinhua PharmaceuticalCompany Limitedq\qge兡N gPlQS(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)ANNOUNCEMENTCHANGE OF DIRECTORS AND SUPERVISORSReference is made to the circular of the Company dated 6 November 2014, the announcement of the Company dated 3 December 2014 and the revised notice of the Company dated 4 December 2014.The Board is pleased to announce that all the following candidates have been re-elected or elected at the EGM held on 22 December 2014 as Directors or Supervisors, as the case may be, by ordinary resolutions passed by the Shareholders attending the EGM. The new term of office of the elected Directors and the Supervisors will be for a period of three years, which is to commence on 22 December 2014 and will expire on the completion of the term of office:Mr. Zhang Daiming and Mr. Du Deping have been re-elected as the executive Directors;Mr. Ren Fulong, Mr. Xu Lie and Mr. Zhao Bin have been re-elected as the non-executive Directors;Mr. Yu Xiong has been elected, and Mr. Chan Chung Kik, Lewis has been re-elected, as the independent non-executive Directors; andMr. Li Tianzhong, Mr. Zhang Yueshun and Mr. Tao Zhichao have been re-elected as the Supervisors, whereas Ms. Hu Yanhua, an employee Supervisor, has been automatically appointed as a Supervisor without election in accordance with Article 113 of the Companys Articles of Association.With effect from 22 December 2014, the composition of the Board has the following changes:the appointment of Mr. Yu Xiong as an independent non-executive Director; andthe cessation of Mr. Zhu Baoquan as an independent non-executive Director and the resignation of Mr. Liu Hongwei as an independent non-executive Director.Mr. Zhu Baoquan confirms that he has no disagreement with the Board and there are no mattes in relation thereto that need to be brought to the attention of the Shareholders or the Stock Exchange.BackgroundThe seventh Board comprised eight Directors including Mr. Zhang Daiming being the Chairman, Mr. Du Deping being executive Directors, Mr. Ren Fulong, Mr. Xu Lie and Mr. Zhao Bin being non-executive Directors and Mr. Zhu Baoquan, Mr. Liu Hongwei and Mr. Chan Chung Kik, Lewis being independent non-executive Directors. The Supervisory Committee comprised four Supervisors, namely, Mr. Li Tianzhong, Mr. Zhang Yueshun, Mr. Tao Zhichao and Ms. Hu Yanhua. In accordance with Articles 91 and 112 of the Articles of Association, all Directors and Supervisors shall hold office for a term of three years and may offer themselves for re-election (save for Ms. Hu Yanhua, who has been appointed as the employee Supervisor by the employees representatives meeting and need not be elected by Shareholders pursuant to Article 113 of the Articles of Association).Election of Directors and SupervisorsReference is made to the circular of the Company dated 6 November 2014, the announcement of the Company dated 3 December 2014 and the revised notice of the Company dated 4 December 2014.The Board is pleased to announce that all the following candidates have been re-elected or elected at the EGM held on 22 December 2014 as Directors or Supervisors, as the case may be, by ordinary resolutions passed by the Shareholders attending the EGM. The new term of office of the elected Directors and the Supervisors will be for a period of three years, which is to commence on 22 December 2014 and will expire on the completion of the term of office:Mr. Zhang Daiming and Mr. Du Deping have been re-elected as the executive Directors;Mr. Ren Fulong, Mr. Xu Lie and Mr. Zhao Bin have been re-elected as the non-executive Directors;Mr. Yu Xiong has been elected, and Mr. Chan Chung Kik, Lewis have been re-elected, as the independent non-executive Directors; andMr. Li Tianzhong, Mr. Zhang Yueshun and Mr. Tao Zhichao have been re-elected as the Supervisors, whereas Ms. Hu Yanhua, an employee Supervisor, has been automatically appointed as a Supervisor without election in accordance with Article 113 of the Companys Articles of Association.Biographical details of each of the re-elected Directors and Supervisors have been disclosed in the circular of the Company dated 6 November 2014. Biographical details of Mr. Yu Xiong are set out in section D of this announcement.Retirement and resignation of DirectorsMr. Zhu Baoquan retired by rotation as an independent non-executive Director with effect from the conclusion of the EGM and has not been proposed to be a candidate for re-election as an independent non-executive Director. Accordingly, Mr. Zhu Baoquan ceased to be an independent non-executive Director on conclusion of the EGM.Mr. Zhu Baoquan confirms that he has no disagreement with the Board and there are no mattes in relation thereto that need to be brought to the attention of the Shareholders or the Stock Exchange.The Board would like to take this opportunity to express its gratitude to Mr. Zhu Baoquan for his support, devotion and invaluable contribution to the Company during his tenure of office.Mr. Liu Hongwei has tendered his resignation as an independent non-executive Director of the Company with effect from 22 December 2014. Reference is made to the announcement of the Company dated 3 December 2014.Biographical details of Mr. Yu XiongMr. Yu XiongMr. Yu Xiong, aged 53, Mr. Yu graduated from Fudan University majoring in Chemistry, and obtained his bachelors degree in July 1984. Mr. Yu is currently a researcher of China State Institute of Pharmaceutical Industry, a part-time professor of Shanghai Jiao Tong University and East China Normal University, and the chairman of the Pharmaceutical Engineering Expert Committee of the Chinese Pharmaceutical Association. He has been received a special allowance issued by the government in 1999. He has been an independent director of Shandong Lukang Pharmaceutical Group Co., Ltd. a director of Shanghai Shyndec Pharmaceutical Co., Ltd. and an independent director of Guangdong Taiantang Pharmaceutical Co., Ltd. Mr. Yu has been an independent non-executive director of Livzon Pharmaceutical Group Inc. since September 2013. Save as disclosed above, Mr. Yu did not hold any other directorship in any listed companies in the past three years or any other positions in the Company or other members of the Group. Mr. Yu has no relationship with any other Directors, senior management or substantial or controlling shareholders of the Company.As at the date hereof, Mr. Yu does not have any interest in the shares of the Company within the meaning of Part XV of the SFO. Mr. Yu has not entered into any service contract with the Company. His emoluments will be determined by reference to his experience and the emoluments of other independent non-executive Directors of the Company. The term of office of Mr. Yu will commence from the date of approval by the Shareholders at the EGM and will end on the expiry of the term of the eighth session of the Board of the Company.Neither Mr. Yu Xiong has anything to be disclosed pursuant to Rules 13.51(2) (h) to (v) of the Listing Rules nor is there anything that needs to be brought to the attention of the Shareholders.DefinitionsIn this announcement, unless otherwise indicated in the context, the following expressions have the meaning set out below:Articles of Associationthe articles of association of the Company Board the board of Directors Company q\qge兡N gPlQS (Shandong Xinhua Pharmaceutical Company Limited), a joint stock company incorporated in the PRC with limited liability Directors the directors of the Company EGM the extraordinary general meeting of the Company held on 22 December 2014Gourpthe Company and its subsidiariesHong KongHong Kong Special Administrative Region of the PRCListing Rulesthe rules governing the listing of the securities on the Stock ExchangePRCthe Peoples Republic of ChinaShareholdersthe shareholders of the CompanyStock ExchangeThe Stock Exchange of Hong Kong LimitedSupervisorsThe supervisors of the CompanySupervisory Committeethe supervisory committee of the Company2_`t u v w y z {    ˹zobXSOSOIBh$CJo( h$CJh$ h$o(h$CJOJQJh$6CJOJQJ]h$0JCJaJo(h$CJo(h$CJPJ h$CJh5[Dh5[DCJPJnHo(tHh5[DCJPJnHo(tHh$CJPJnHo(tH"jh5[DCJUmHnHtHuhIh$CJaJhIhICJ]aJo(hIhICJ]aJjhIh$CJUaJu w x y z {   ` b l m 6+$$d%d&d'd7$8$H$NOPQa$$a$$G$H$a$$G$H$a$$a$G$H$$G$H$a$$G$H$a$iii $ & b . F T j %CDݻ{{{{pdݻY{{{h{ehKHaJh{ehfKHaJo(h{ehfKHaJh{eh$KHaJ#h{eh2ZKHPJaJnHo(tH h{eh2ZKHPJaJnHtH#h{eh<KHPJaJnHo(tHh{ehIKHaJh{eh2ZKHaJo(h{eh2ZKHaJh{eh$KHaJo(h{eh$o(h{eh2Zo( h{eh2Z"56789;HIM[w˿ˑ˿vj[K˿˿h{eh KHPJnHo(tHh{ehIKHPJnHtHh{eh KHaJo(h{eh KHaJh{ehIKHPJnHo(tHh{eh<KHPJnHo(tHh{ehIKHaJh{eh@p KHaJh{eh$o(h{eh$KHaJo(h{eh$KHaJ#h{eh<KHPJaJnHo(tHh{ehKHaJh{ehKHaJo(67W*$ & F$d%d&d'dNOPQa$)$$d%d&d'dNOPQa$gd -$ & F$d%d&d'dNOPQa$gd &$$d%d&d'dNOPQa$ +,./?AGkpqrٿ|ufZOfh{ehKHaJh{ehKHaJo(h{ehKHPJnHtH h{ehIh{eh KHaJh{eho( h{eh$h{ehIKHaJ#h{eh<KHPJaJnHo(tHh{eh$KHaJo(h{eh$KHaJh{ehIKHPJnHtHh{eh<KHPJnHo(tHh{ehIKHPJnHo(tH h{eh qr~TT)$$d%d&d'dNOPQa$gdI*$ & F$d%d&d'dNOPQa$)$$d%d&d'dNOPQa$gd-$ & F$d%d&d'dNOPQa$gdI 789NY]`ʻꩰʎ~oo`XPh{eh$o(h{ehHo(h{ehIKHPJnHtHh{ehHKHPJnHtH h{ehIh{eh2ZKHh{eh/KKH#h{eh/KKHPJaJnHo(tH hRhh{ehKHaJh{ehKHPJnHtHh{eh/KKHPJnHo(tHh{ehKHPJnHo(tH h{ehhRh/KPJnHo(tH89~~~yymdd $7$8$H$a$  & F0`0gd<~$a$)$$d%d&d'dNOPQa$gdI)$$d%d&d'dNOPQa$gd-$ & F$d%d&d'dNOPQa$gd -=ALPXlm{ #'5豦豖ֱ豖vk豖h{eh:KHaJh{eh@p KHPJnHo(tHh{eh/+KHPJnHo(tHh{eh KHPJnHo(tHh{eh:QKHaJh{eh:QKHPJnHtHh{eh KHaJh{eh@p KHaJ#h{eh/+KHPJaJnHo(tHh{eh$KHaJh{eh$KHaJo(*59FGHLW[\`i  %/3KXp"#·sl]h{eh'cKHPJnHtH h{eh'ch{eh@p KHaJo(h{ehfKHaJh{eh@p KHaJh{eh$KHaJo(h{eh$KHaJh{eh:QKHaJh{eh:KHaJh{eh:KHPJnHo(tHh{eh:KHPJnHtHh{eh KHPJnHo(tHh{eh:QKHPJnHtH!"#`a $7$8$H$a$gdLG$ & F7$8$H$a$gd9}gd'c$h7$8$H$^ha$gd'c$ & F7$8$H$a$gd'c $7$8$H$a$gd'c  & F0`0gd<~ $7$8$H$a$#Z[ghij"&)+ILTcdef^lmnųų֖ֆֆwh{eh'cKHPJnHtHh{eh'cKHPJnHo(tH#h{ehlfKHPJaJnHo(tHh{eh<~KHaJ#h{eh2ZKHPJaJnHo(tH h{eh2ZKHPJaJnHtHh{eh'cKHaJ#h{ehUKHPJaJnHo(tHh{eh'cKHaJo(.+FTU^_aem~DE$01>?Jȹ㪟tih{ehLKHaJh{eh/DKHaJh{ehMoKHaJh{eh'cKHh{ehLGKHaJo(h{eh9}KHaJh{eh9}KHaJmH sH h{eh'cKHPJnHtHh{ehlfKHPJnHo(tHh{eh'cKHaJh{eh'cKHaJo(h{eh'cKHPJnHo(tH#"ŵג}v}nbSCh{eh[KHPJnHo(tHh{ehfKHPJnHtHh{eh$KHaJo(h{ehfo( h{ehm;h{ehm;PJnHo(tH h{ehf&h{ehqD5KHPJaJnHo(tHh{ehe/KHPJnHtHh{ehlfKHPJnHo(tHh{ehe/KHaJ h{ehe/h{eh'cKHaJh{ehqDKHaJ#h{ehlfKHPJaJnHo(tH[\ ![$\$n&o&1'2'>'$a$gde/ $7$8$H$a$gdXs $7$8$H$a$gd8U^gd8U  & F0`0gd<~ $7$8$H$a$gd[$a$ $7$8$H$a$"9=@YZ[\`koz+浦j[[h{eh[KHPJnHtH,h{eh$B*OJPJQJnHo(phtHh{eh<~KHPJnHtHh{ehLKHaJh{eh:QKHaJh{eh:QKHPJnHtHh{eh[KHPJnHo(tHh{eh[KHaJh{ehCKHaJh{eh",KHaJh{ehfKHPJnHtHh{ehfKHaJ+34dfz[$\$n&¶wgWwH8Hh{ehXsKHPJnHo(tHh{ehXsKHPJnHtHh{eh8U5PJnHo(tHh{eho5PJnHo(tHh{eh8U5h{ehoPJnHo(tH h{eh8Uh{eh[KHPJnHo(tH#h{ehoKHPJaJnHo(tHh{ehoKHaJo(h{ehKHPJnHo(tHh{eh[KHPJnHtHh{eh2ZKHPJnHo(tHh{eh2ZKHPJnHtHn&o&v&{&&&&&&&&&&/'0'1'2'>'?''''''''((((B(D(R(T(`)b)t)v))))κwgwgwgwgwgwgwgwgwgh{eh$KHOJQJaJo(h{eh$KHOJQJaJh{eh$KHOJQJo(h{eh$KHOJQJ h{eh$B*OJQJo(phh{eh$o(h{ehe/PJnHtH h{eh& h{eh"qh{ehaPJnHo(tH h{eh}  h{ehNph{eh"qPJnHo(tH(>'?''''(((@(Lkd$$If0 ! 464 a$$7$8$H$IfYDda$ $7$8$H$a$$a$@(B(V(^)`)x))ULkd$$If0 ! 464 a$$7$8$H$IfYDda$Lkdk$$If0 ! 464 a)))**+*3*T*@Lkd$$If0 ! 464 a$$7$8$H$IfYDda$gd<~$$7$8$H$IfYDda$LkdA$$If0 ! 464 a))'*(*)***+*,*1*2*3*S*T*U*V*_*`*********++!+"+D+Ҽ{{{k\Lh{eh&KHOJQJaJo(h{eh&KHOJQJaJh{ehm^KHOJQJaJo(+h{ehm^KHOJPJQJaJnHo(tH(h{ehm^KHOJPJQJaJnHtH+h{eh$KHOJPJQJaJnHo(tH+h{ehaKHOJPJQJaJnHo(tHh{eh<~KHOJQJaJh{eh$KHOJQJaJo(h{eh$KHOJQJaJT*U*a*****U@$$7$8$H$IfYDda$gd&Lkd$$If0 ! 464 a$$7$8$H$IfYDda$Lkd$$If0 ! 464 a***++#+C+ULkdX$$If0 ! 464 a$$7$8$H$IfYDda$Lkd$$If0 ! 464 aC+D+U+}+~+++ULkd.$$If0 ! 464 a$$7$8$H$IfYDda$Lkd$$If0 ! 464 aD+E+S+T+~+++++++++++h(hNhOhWhdhehfhohphqhrhhhhƸteYeNh]"h]"OJQJh]"hOJQJo(haOJPJQJnHo(tHh$CJOJQJo( h$o(h$6OJQJ]o(h$h$5OJQJ\o(h$h$5OJQJ\h$5OJQJ\h$5OJQJ\o(Uh$OJQJo(#h{eh$CJKHOJQJaJo(h{eh$KHOJQJaJo(h{eh$KHOJQJaJ++++++++ULG> $$Ifa$$a$ $7$8$H$a$Lkd$$If0 ! 464 a$$7$8$H$IfYDda$Lkd$$If0 ! 464 aYours faithfully,By order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang Daiming Chairman22 December 2014, Zibo, the PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingIndependent Non-executive Directors:Mr. Yu XiongMr. Chan Chung Kik, LewisNon-executive Directors: Mr. Ren FulongMr. Xu LieMr. Zhao BinPAGE PAGE 2+h(hWhfhohphqhrhhhhhhr$$G$Ifa$gdZ[Q $G$a$gda$7$8$G$H$a$gda$a$Nkdo$$If'0 q# #64 a $$Ifa$gd$ $$Ifa$hhhhhhhhhhhhii9iAiBiFi[i]i^iiiiiiiiiiiiiiiiii˾}wokokokokajhb0JUhTjhTU h$CJhah$CJKHaJo(h9%hao( h9%hahaPJnHo(tHh9%haPJnHo(tHh6=haKHaJh9%haPJnHtHh$CJOJQJo(h]"h$OJQJo(h]"OJQJh]"OJQJo(h]"h]"OJQJo(%hiii5iBi\i]i^ixiiiiiQkd$$If0!644 aytZ[Q$$G$Ifa$gdZ[Qiiiiiiiiiiiiiiiii$a$&`#$$a$ $7$8$H$a$Qkd3$$If0!644 aytZ[Qiiiiiiiiiiiiiiiiiiii h$CJhphbCJaJ hbCJhT hbo(hR0JmHnHuhbjhb0JU hb0Jiiiiiiiii$a$d/0P/ =!"#$% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB0 Char CharKHmH nHsH tH.. yyblFhe,gCJaJFOF XsPa8dB*OJPJQJnHphtHi#i#vuwxyz{()6Z[6778~C D E F Q R RS  \]deYZf > ? O '!(!6!U!V!n!!!!!!!!!" " " ""-"."i"j""""""""""#"#-#:#;#<#=#>#@#A#C#D#F#G#I#J#S#T#U#`#a#b#c#d#e#f#g#j#08000000000000(0)@0606@06@06@06 06@06 06@06 06@06 06@06@0606 0606 06@06@06@06@06@06 0)@0F @0F @0F  0)@0 0 @0 @0 @0  0 @0  0 @0  0 @0  0 @0 @0 @0  0)@0@0@0@0@0@0@00@0 0)@0)@0@0@0@0@0@0@0@0 0)@0@0@0@ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @ @ @0 @0@0@0 @0@0@0@0@0 @0 0000000000 0000 0 0000 0 0 00@0ȑ00F@0ȑ00F@0ȑ00F@0ȑ00F@0@0@0@0@0@0ȑ00dF00000()6Z[j#ȑ00Tȑ00ȑ00C300RMU=VWX00ʑ00dF $$$' 5#"+n&)D+hii !#$%'()-1696>'@()T**C+++hiii"&*+,./02578:i  '!!l,b$l?xK-}*1v@P(  V  # "?V  # "?\  S A"?B S  ?ui#$P(r$8P(r `tbH'cHdHeH fHT gH hHԡ iH jHT kH lHԢ mH nHT oH pHԣ qH rHT sH tHԤ uH  ""j#      #"#"j#    B*urn:schemas-microsoft-com:office:smarttagscountry-region9*urn:schemas-microsoft-com:office:smarttagsplace=*urn:schemas-microsoft-com:office:smarttags PlaceName=*urn:schemas-microsoft-com:office:smarttags PlaceType8*urn:schemas-microsoft-com:office:smarttagsCity ;>?EKM#,8?LSLS - 4 > E Y \   ]dpv=@^c$|7@(-!!""""""""###!#&#(#>#>#@#@#A#A#C#D#F#G#I#J#b#c#j#X>#>#@#@#A#A#C#D#F#G#I#J#b#c#j#3335F R  ? O !!!!" "".""">#>#@#@#A#A#C#D#F#G#I#J#b#c#j#>#>#@#@#A#A#C#D#F#G#I#J#b#c#j#F:04qs,ƅeL6\ ?I?M^Vsq4m2|hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`CJPJ o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.hh^h`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.:0?I?^VFq4meL6qs,lB        >                                8 4                dcJKS<o}  @p G #`e<~ X2:)H]"UW$q%r'r,",e/y9m;3%A'4BD5[D/kDqDLcNZ[QRgT8U_Z[*b'cx:|/+aJg:CC;IUNpLG/K&/D6deYZf > ? O '!(!6!U!V!n!!!!!! " "i"j"""":#;#<#j# =!"@[L!i#@@@ @@@(@T@@@Unknown Gz Times New Roman5Symbol3& z Arial;[SOSimSun_ Times-RomanTimes New Roman] Times-BoldTimes New RomanC .PMingLiUe0}fԚ;& HelveticaGTimes LT Std[SOKE  DFKai-SBPMingLiU 1h,'J'B?B?!?!),.:;?]}    " % & ' 2 t%00 0 000000013468:<>@BDOPQRTUVWZ\^ \]d([{  5 0 0 00000579;=?ACY[][,#,# 2qHX?2~The Board currently comprises eight Directors including Guo Qin being the Chairman, Ren Fulong and Zhao Songguo being executiv CARRIECHENGhggSf(       Oh+'0(4HT`p    The Board currently comprises eight Directors including Guo Qin being the Chairman, Ren Fulong and Zhao Songguo being executiv CARRIECHENGNormal39Microsoft Office Word@@C&@Y@!NB՜.+,0 X`t|  Charltons?,#'   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPRSTUVWXZ[\]^_`abcdefghijklmnopqrstuvwxyz{|~Root Entry Fp/kData Q1TableYGWordDocumentSummaryInformation(}DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q